Elevated pAXL expression was associated with improved survival, particularly among male patients, and correlated with increased levels of fibronectin and phosphorylated AKT, both involved in cancer invasiveness and epithelial–mesenchymal transition (EMT). The gene discussed is FN1; the disease is cancer.